From: Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort
 | Tertiles | Cases/Controls | Crude ORa (95% CI) | Adjusted ORb (95% CI) |
---|---|---|---|---|
Estradiol (pg/ml) | ||||
 |     1 | 42/75 | 1.00 (Reference) | 1.00 (Reference) |
 |     2 | 30/75 | 0.67 (0.38-1.18) | 0.62 (0.34-1.15) |
 |     3 | 32/75 | 0.71 (0.39-1.27) | 0.69 (0.35-1.35) |
 |     P for trend | 0.21 | 0.25 | |
Progesterone (ng/ml) | ||||
 |     1 | 32/75 | 1.00 (Reference) | 1.00 (Reference) |
 |     2 | 42/75 | 1.19 (0.69-2.06) | 1.56 (0.83-2.97) |
 |     3 | 30/75 | 0.92 (0.50-1.69) | 1.16 (0.60-2.27) |
 |     P for trend | 0.81 | 0.75 | |
Total testosterone (ng/ml) | ||||
 |     1 | 33/75 | 1.00 (Reference) | 1.00 (Reference) |
 |     2 | 37/80 | 1.03 (0.56-1.90) | 1.07 (0.56-2.04) |
 |     3 | 34/70 | 1.11 (0.58-2.14) | 1.27 (0.62-2.61) |
 |     P for trend | 0.75 | 0.51 | |
Free testosterone (pg/ml) | ||||
 |     1 | 20/75 | 1.00 (Reference) | 1.00 (Reference) |
 |     2 | 41/75 | 2.30 (1.15-4.58) | 2.31 (1.12-4.76) |
 |     3 | 43/75 | 2.20 (1.12-4.32) | 2.43 (1.15-5.10) |
 |     P for trend | 0.03 | 0.03 | |
SHBG (mmol/ml) | ||||
 |     1 | 41/75 | 1.00 (Reference) | 1.00 (Reference) |
 |     2 | 29/77 | 0.68 (0.38-1.21) | 0.66 (0.36-1.21) |
 |     3 | 34/73 | 0.86 (0.48-1.55) | 0.93 (0.50-1.72) |
 |     P for trend | 0.60 | 0.78 |